News

One, it makes sense for AstraZeneca Plc to move its main listing to New York, and two, such a terrible symbolic blow for the ...
Imugene is tapping the market for up to $35 million, while Clever Culture Systems and Compumedics are soaring on positive ...
Danaher Corporation (NYSE:DHR) is a leading global life sciences and diagnostics innovation company. With a focus on science ...
Shares of AstraZeneca PLC AZN shed 1.66% to £104.50 Friday, on what proved to be an all-around dismal trading session for the ...
Norman Lamont warns AstraZeneca quitting London Stock Exchange could be a devastating blow to the UK economy and its status.
AstraZeneca PLC closed 20.63% short of its 52-week high of £133.88, which the company achieved on September 3rd.
AstraZeneca’s stock market exit would be devastating blow, warns ex-chancellor - The UK is ‘a hostile environment’ for ...
AstraZeneca may have washed its hands of AZD4041 after the opioid use disorder (OUD) prospect demonstrated a potential drug-drug interaction last year, but the pharma’s development partner, Eolas T | ...
"attachment_1220866" align="aligncenter" width="1456"] A laboratory employee in a sterile environment inspecting a microscope ...
Regarding the value of this meeting of the Anglican Communion Science Commission, Dr Heather went on to say, “The discussion is important and for bishops to weigh in with their input into ethics, they ...
TIGIT-targeting therapies have largely disappointed in recent months, with failed studies, terminated partnerships and ...
The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...